drugset / Trial / NCT00671879
Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carisoprodol | Small molecule | 500 mg | — |
| Subject | Carisoprodol | Small molecule | 700 mg | — |
Indications
No indication recorded.